JP Morgan Chase
PFE icon

JP Morgan Chase’s Pfizer PFE Stock Holding History

JP Morgan Chase’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.5M Sell
1,350,400
-337,200
-20% -$8.98M ﹤0.01% 1584
2025
Q4 		$42M Buy
1,687,600
+379,600
+29% +$9.57M ﹤0.01% 1474
2025
Q3 		$33.3M Sell
1,308,000
-510,700
-28% -$12.6M ﹤0.01% 1687
2025
Q2 		$44.1M Sell
1,818,700
-3,276,900
-64% -$76.4M ﹤0.01% 1401
2025
Q1 		$129M Buy
5,095,600
+2,482,700
+95% +$65M 0.01% 821
2024
Q4 		$69.3M Buy
2,612,900
+2,038,500
+355% +$55.3M 0.01% 1125
2024
Q3 		$16.6M Buy
574,400
+307,800
+115% +$8.98M ﹤0.01% 2154
2024
Q2 		$7.46M Sell
266,600
-308,300
-54% -$8.49M ﹤0.01% 2720
2024
Q1 		$16M Sell
574,900
-483,700
-46% -$13.4M ﹤0.01% 2079
2023
Q4 		$30.5M Buy
1,058,600
+1,012,500
+2,196% +$30.6M ﹤0.01% 1518
2023
Q3 		$1.53M Sell
46,100
-86,700
-65% -$3.07M ﹤0.01% 3760
2023
Q2 		$4.87M Sell
132,800
-530,300
-80% -$20.6M ﹤0.01% 2883
2023
Q1 		$27.1M Sell
663,100
-815,600
-55% -$35.2M ﹤0.01% 1451
2022
Q4 		$75.8M Buy
1,478,700
+69,700
+5% +$3.34M 0.01% 901
2022
Q3 		$61.7M Buy
1,409,000
+70,300
+5% +$3.42M 0.01% 949
2022
Q2 		$70.2M Buy
1,338,700
+514,800
+62% +$26.2M 0.01% 894
2022
Q1 		$42.7M Sell
823,900
-761,800
-48% -$39.5M 0.01% 1254
2021
Q4 		$93.6M Buy
1,585,700
+740,800
+88% +$36.7M 0.01% 926
2021
Q3 		$36.3M Buy
844,900
+166,400
+25% +$7.37M ﹤0.01% 1349
2021
Q2 		$26.6M Buy
678,500
+594,000
+703% +$23.1M ﹤0.01% 1594
2021
Q1 		$3.06M Sell
84,500
-806,472
-91% -$28.6M ﹤0.01% 3384
2020
Q4 		$32.8M Sell
890,972
-1,400,529
-61% -$51.4M ﹤0.01% 1294
2020
Q3 		$78.6M Buy
2,291,501
+1,202,824
+110% +$42.2M 0.01% 783
2020
Q2 		$33.8M Sell
1,088,677
-30,882
-3% -$1.05M 0.01% 1059
2020
Q1 		$34.7M Sell
1,119,559
-172,329
-13% -$5.87M 0.01% 956
2019
Q4 		$48M Sell
1,291,888
-295,014
-19% -$10.5M 0.01% 985
2019
Q3 		$54.1M Buy
1,586,902
+1,070,653
+207% +$38.9M 0.01% 908
2019
Q2 		$21.3M Buy
516,249
+131,117
+34% +$5.21M ﹤0.01% 1531
2019
Q1 		$15.5M Sell
385,132
-730,211
-65% -$29.2M ﹤0.01% 1722
2018
Q4 		$46.2M Buy
1,115,343
+70,829
+7% +$2.94M 0.01% 933
2018
Q3 		$43.7M Buy
1,044,514
+298,914
+40% +$11.5M 0.01% 1093
2018
Q2 		$25.7M Sell
745,600
-297,333
-29% -$10.2M 0.01% 1402
2018
Q1 		$35.1M Sell
1,042,933
-1,335,945
-56% -$45.9M 0.01% 1146
2017
Q4 		$81.7M Sell
2,378,878
-295,436
-11% -$10.1M 0.02% 748
2017
Q3 		$90.3M Buy
2,674,314
+1,434,072
+116% +$46.1M 0.02% 662
2017
Q2 		$39.5M Buy
1,240,242
+80,842
+7% +$2.55M 0.01% 1038
2017
Q1 		$37.6M Sell
1,159,400
-168,535
-13% -$5.31M 0.01% 1083
2016
Q4 		$40.9M Buy
1,327,935
+293,624
+28% +$8.96M 0.01% 1008
2016
Q3 		$33.2M Sell
1,034,311
-28,985
-3% -$969K 0.01% 1046
2016
Q2 		$35.5M Buy
1,063,296
+317,591
+43% +$10.1M 0.01% 1012
2016
Q1 		$21M Sell
745,705
-1,146,541
-61% -$32.7M 0.01% 1302
2015
Q4 		$58M Buy
1,892,246
+1,533,570
+428% +$48.2M 0.01% 748
2015
Q3 		$10.7M Sell
358,676
-737,800
-67% -$23.7M ﹤0.01% 1713
2015
Q2 		$34.9M Buy
1,096,476
+102,449
+10% +$3.34M 0.01% 1061
2015
Q1 		$32.8M Buy
994,027
+251,920
+34% +$8.01M 0.01% 1116
2014
Q4 		$21.9M Sell
742,107
-1,431,241
-66% -$41M 0.01% 1411
2014
Q3 		$61M Buy
2,173,348
+1,171,943
+117% +$32.9M 0.01% 807
2014
Q2 		$28.2M Buy
1,001,405
+1,001,300
+953,619% +$28.5M 0.01% 1133
2014
Q1 		$3K Sell
105
-1,466,593
-100% -$43.7M ﹤0.01% 3547
2013
Q4 		$42.6M Buy
1,466,698
+1,193,290
+436% +$34.7M 0.01% 895
2013
Q3 		$7.45M Buy
273,408
+106
+0% +$2.88K ﹤0.01% 1939
2013
Q2 		$7.26M Buy
+273,302
New +$7.55M ﹤0.01% 1877

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase's PFE Position: Q1 2026 in Review

JP Morgan Chase increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $121M and bringing the position to 27,894,042 shares worth $775M. The position accounts for 0.05% of the portfolio, ranked #312.

JP Morgan Chase first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.92B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • JP Morgan Chase held 27,894,042 shares of Pfizer worth $775M as of Q1 2026.
  • JP Morgan Chase bought 4,552,595 Pfizer shares in Q1 2026, an estimated $121M.
  • Pfizer made up 0.05% of JP Morgan Chase's portfolio in Q1 2026, its #312 holding.
  • JP Morgan Chase first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Pfizer position peaked at $4.92B in Q3 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.